Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4,4'-dithio(bis(3-aminobutyl Sulfonic Acid))
2. Rb 150
3. Rb-150
4. Rb150
5. Rb150 Cpd
1. Qgc-001
2. 648927-86-0
3. Rb-150
4. Qgc001
5. Rb150
6. 638ky4573i
7. 1-butanesulfonic Acid, 4,4'-dithiobis(3-amino-, (3s,3's)-
8. (s)-3-amino-4-(((s)-2-amino-4-sulfobutyl)disulfaneyl)butane-1-sulfonic Acid
9. Unii-638ky4573i
10. Qgc 001
11. Firibastat [inn]
12. Firibastat [who-dd]
13. Schembl1694944
14. Chembl4297511
15. (3s,3's)-4,4'-dithiobis(3-aminobutane-1-sulfonic Acid)
16. Glxc-25368
17. Db13107
18. Hy-109058
19. Cs-0032985
20. 4,4'-dithio(bis(3-aminobutyl Sulfonic Acid))
21. Q27263587
22. (3s,3's)-4,4'-disulfanediylbis(3-aminobutane-1-sulfonicacid)
23. (3s,3s')-4,4'-disulfanediylbis(3-aminobutane-1-sulfonic Acid)
24. (3s)-3-amino-4-[[(2s)-2-amino-4-sulfobutyl]disulfanyl]butane-1-sulfonic Acid
25. 1601301-49-8
| Molecular Weight | 368.5 g/mol |
|---|---|
| Molecular Formula | C8H20N2O6S4 |
| XLogP3 | -6.9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | 368.02042106 g/mol |
| Monoisotopic Mass | 368.02042106 g/mol |
| Topological Polar Surface Area | 228 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 410 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Firibastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Firibastat, including repackagers and relabelers. The FDA regulates Firibastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Firibastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Firibastat supplier is an individual or a company that provides Firibastat active pharmaceutical ingredient (API) or Firibastat finished formulations upon request. The Firibastat suppliers may include Firibastat API manufacturers, exporters, distributors and traders.
Firibastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Firibastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Firibastat GMP manufacturer or Firibastat GMP API supplier for your needs.
A Firibastat CoA (Certificate of Analysis) is a formal document that attests to Firibastat's compliance with Firibastat specifications and serves as a tool for batch-level quality control.
Firibastat CoA mostly includes findings from lab analyses of a specific batch. For each Firibastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Firibastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Firibastat EP), Firibastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Firibastat USP).
LOOKING FOR A SUPPLIER?
